Cargando...
COVID-19 and the nicotinic cholinergic system
The prevalence of smoking among hospitalised COVID-19 patients is low. COVID-19 manifestations could be linked to impairment of the cholinergic anti-inflammatory pathway. Nicotinic cholinergic agonists should be examined as potential therapeutic options. https://bit.ly/2zfUZ1S
Guardado en:
| Publicado en: | Eur Respir J |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
European Respiratory Society
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7248130/ https://ncbi.nlm.nih.gov/pubmed/32444400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.01589-2020 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|